Epidemiology, Temporal Trends and Resistance Patterns of ESBL-Producing Non-Typhoidal Salmonella Isolated from Blood Cultures in Kisantu, DRC (2019–2022)
Authors:
- Jules MbuyambaJules Mbuyamba
- Gaelle Nkoji-TundaGNGaelle Nkoji-Tunda
- Daniel VitaDVDaniel Vita
- Laurence NgaraLNLaurence Ngara
- Edmonde BonebeEBEdmonde Bonebe
- Marie-France PhobaMPMarie-France Phoba
- Anne-Sophie HeroesAHAnne-Sophie Heroes
- Mohamadou SiribieMSMohamadou Siribie
- Birkneh Tilahun TadesseBTBirkneh Tilahun Tadesse
- Glody-Nickel MbaaGMGlody-Nickel Mbaa
- Florian MarksFMFlorian Marks
- Liselotte HardyLiselotte Hardy
Open Access
- 6 March 2026
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 15 (3) , 271
Abstract
Background: Antimicrobial resistance (AMR), particularly due to extended-spectrum beta-lactamases (ESBL), is a growing threat to public health in sub-Saharan Africa. This study investigates the prevalence, epidemiological characteristics, resistance patterns and resistance dynamic over time of ESBL-producing non-typhoidal Salmonella (NTS) bacteremia in Kisantu, Democratic Republic of Congo (DRC), from 2019 to 2022. Methods: A retrospective observational study used routine bloodstream infection data from the AMR network at Saint Luc Hospital in Kisantu. Blood cultures from suspected bacteremia cases were processed using standard microbiological techniques. Bacterial identification relied on biochemical reactions. Antibiotic susceptibility testing and ESBL-producing NTS detection were performed by disk diffusion following Clinical and Laboratory Standards Institute guidelines. Associations between ESBL production and patient characteristics (age, sex) were assessed using Pearson’s Chi-square test, and annual temporal trends in ESBL-producing NTS from 2019 to 2022 were analyzed by logistic regression using 2019 as the reference year. Results: Of the 19,430 blood cultures, 1681 NTS isolates were identified, and 1568 of these were screened for ESBL. ESBL prevalence was significantly associated with age (p = 0.007), peaking in children under 2 years, but not with sex (p = 0.570). Compared with 2019, the likelihood of isolating ESBL-producing NTS increased markedly through 2022, with adjusted probabilities rising from 58% to 87%, reflecting a strong upward temporal trend. High levels of extensively drug-resistant (94.1%) were observed. No carbapenem resistance was detected. Conclusions: ESBL-producing NTS bacteremia is rising in Kisantu, DRC, mainly affecting children under 2 years. Rising resistance to key antibiotics limits treatment options and highlights the need for strengthened AMR surveillance, optimized antibiotic use, and vaccination strategies.Keywords
All Related Versions
Funding Information
- Belgian Directorate of Development Cooperation and Humanitarian Aid
- SETA (Severe Typhoid in Africa) project
- Bill and Melinda Gates Foundation (OPP1127988)
- European and Developing Countries Clinical Trials Partnership (RIA2017S-2027)
This publication has 28 references indexed in Scilit:
- Efficacy of susceptibility-matched antibiotic treatment of nontyphoidal Salmonella bloodstream infections: a prospective observational study in hospitalized children under 5 in the Democratic of CongoClinical Microbiology and Infection, 2025
- Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative InfectionsClinical Infectious Diseases, 2024
- Incidence of typhoid fever in Burkina Faso, Democratic Republic of the Congo, Ethiopia, Ghana, Madagascar, and Nigeria (the Severe Typhoid in Africa programme): a population-based studyThe Lancet Global Health, 2024
- Epidemiological cut-off value and antibiotic susceptibility test methods for azithromycin in a collection of multi-country invasive non-typhoidal SalmonellaClinical Microbiology and Infection, 2022
- Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS)The Lancet Infectious Diseases, 2021
- The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017The Lancet Infectious Diseases, 2019
- Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance studyThe Lancet Global Health, 2017
- InvasiveSalmonellaInfections at Multiple Surveillance Sites in the Democratic Republic of the Congo, 2011–2014Clinical Infectious Diseases, 2015
- Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatmentSaudi Journal of Biological Sciences, 2015
- Étude descriptive des bactériémies à Salmonella non typhi chez les patients infectés par le VIH au CHU de Dakar (Sénégal)Medecine Et Maladies Infectieuses, 2008